These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Normal and gene-corrected dystrophic epidermolysis bullosa fibroblasts alone can produce type VII collagen at the basement membrane zone. Woodley DT; Krueger GG; Jorgensen CM; Fairley JA; Atha T; Huang Y; Chan L; Keene DR; Chen M J Invest Dermatol; 2003 Nov; 121(5):1021-8. PubMed ID: 14708601 [TBL] [Abstract][Full Text] [Related]
7. SIN retroviral vectors expressing COL7A1 under human promoters for ex vivo gene therapy of recessive dystrophic epidermolysis bullosa. Titeux M; Pendaries V; Zanta-Boussif MA; Décha A; Pironon N; Tonasso L; Mejia JE; Brice A; Danos O; Hovnanian A Mol Ther; 2010 Aug; 18(8):1509-18. PubMed ID: 20485266 [TBL] [Abstract][Full Text] [Related]
8. Correction of Recessive Dystrophic Epidermolysis Bullosa by Transposon-Mediated Integration of COL7A1 in Transplantable Patient-Derived Primary Keratinocytes. Latella MC; Cocchiarella F; De Rosa L; Turchiano G; Gonçalves MAFV; Larcher F; De Luca M; Recchia A J Invest Dermatol; 2017 Apr; 137(4):836-844. PubMed ID: 28027893 [TBL] [Abstract][Full Text] [Related]
9. Fibroblasts show more potential as target cells than keratinocytes in COL7A1 gene therapy of dystrophic epidermolysis bullosa. Goto M; Sawamura D; Ito K; Abe M; Nishie W; Sakai K; Shibaki A; Akiyama M; Shimizu H J Invest Dermatol; 2006 Apr; 126(4):766-72. PubMed ID: 16439972 [TBL] [Abstract][Full Text] [Related]